Green Organic Dutchman Holdings Ltd (OTCMKTS:TGODF) recently unveiled its Global Strategic Hemp Division through which it plans to expand its presence into the global organic CBD and hemp market.
The newly launched Global Strategic Hemp Division will take advantage of The Green Organic Dutchman’s knowledge of the hemp CBD market in Europe. This will allow the company to fast-track its growth and also speed up the production and commercialization of new offerings throughout its network with the help of its international partners.
“With the global CBD market expected to hit $22 billion in less than 3 years, it is clear that the segment is drawing substantial consumer demand,” stated TGOD CEO, Brian Athaide.
TGOD already has the technical know-how that it needs to expand in
The CEO also noted in his statement that the company’s team has years of experience in the CBD sector and that they are excited about using that experience in the expansion strategy. Athaide also added that CBD is the ideal product for the company because it aligns with TGOD’s focus on organic products. The
CEO also believes that now is the ideal time to focus on a global expansion strategy because CBD is increasingly gaining more popularity across that world. TGOD has also been building up its business in preparation for more market share. For example, it acquired HemPoland last year, which allowed it to gain access to more intellectual property.
The acquisition seems to have paid off because HemPoland’s Q1 2019 revenue grew by roughly 30% due to the rising demand for top-grade CBD products in the European region. Meanwhile, the new Global Strategic Hemp Division is a great addition, especially to TGOD’s international partners. Some of those partners offer training for standard operating procedures, organic methods and they even provide genetics and regulatory insights.
TGOD has already secured a distribution agreement through its partnership with a German pharmaceutical called Mediakos through HemPoland. TGOD also plans to leverage its existing partnerships as part of its plan to venture into the U.S CBD market. Meanwhile, the company already has a Canadian subsidiary whose operations in the country are licensed by Health Canada.